These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32643093)

  • 1. The role of lipid peroxidation in individuals with autism spectrum disorders.
    Yui K; Imataka G; Sasaki H; Shiroki R
    Metab Brain Dis; 2020 Oct; 35(7):1101-1108. PubMed ID: 32643093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid Peroxidation With Implication of Organic Pollution in Autistic Behaviors.
    Yui K; Imataka G; Sasaki H; Shiroki R; Koshiba M
    Cureus; 2021 Mar; 13(3):e14188. PubMed ID: 33936898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive Interaction Between Plasma Omega-3 Fatty Acids and Arachidonic Acid is Related to Down-Regulation of A Signaling Mediator.
    Yui K; Imataka G; Kawasaki Y
    Med Chem; 2016; 12(4):318-27. PubMed ID: 26740205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ω-3 polyunsaturated fatty acid/arachidonic acid ratios and upregulation of signaling mediator in individuals with autism spectrum disorders.
    Yui K; Imataka G; Kawasak Y; Yamada H
    Life Sci; 2016 Jan; 145():205-12. PubMed ID: 26724495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of a signaling mediator in association with lowered plasma arachidonic acid levels in individuals with autism spectrum disorders.
    Yui K; Imataka G; Kawasaki Y; Yamada H
    Neurosci Lett; 2016 Jan; 610():223-8. PubMed ID: 26552013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships of Fatty Acids, Delta-5 Desaturase Activity, and Lipid Profiles in Men with Acute Coronary Syndrome.
    Arai K; Koba S; Yokota Y; Tsunoda F; Tsujita H; Kondo S; Tsukamoto S; Shoji M; Shinke T
    J Atheroscler Thromb; 2020 Nov; 27(11):1216-1229. PubMed ID: 32595194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Long Chain n-3 Polyunsaturated Fatty Acids and Autism Spectrum Disorder: Systematic Review and Meta-Analysis of Case-Control and Randomised Controlled Trials.
    Mazahery H; Stonehouse W; Delshad M; Kruger MC; Conlon CA; Beck KL; von Hurst PR
    Nutrients; 2017 Feb; 9(2):. PubMed ID: 28218722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fish oil fatty acids on plasma lipids and lipoproteins and oxidant-antioxidant imbalance in healthy subjects.
    Foulon T; Richard MJ; Payen N; Bourrain JL; Beani JC; Laporte F; Hadjian A
    Scand J Clin Lab Invest; 1999 Jul; 59(4):239-48. PubMed ID: 10463462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a novel ELISA for measurement of MDA-LDL in human plasma.
    Bevan RJ; Durand MF; Hickenbotham PT; Kitas GD; Patel PR; Podmore ID; Griffiths HR; Waller HL; Lunec J
    Free Radic Biol Med; 2003 Sep; 35(5):517-27. PubMed ID: 12927601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses.
    Leigh-Firbank EC; Minihane AM; Leake DS; Wright JW; Murphy MC; Griffin BA; Williams CM
    Br J Nutr; 2002 May; 87(5):435-45. PubMed ID: 12010583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.
    Jiang XL; Li M; Zhou JG; Yang QB; Du LJ; Du J
    Cell Biochem Biophys; 2011 Nov; 61(2):461-6. PubMed ID: 21748243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic effects of larger doses of arachidonic acid added to DHA on social impairment and its relation to alterations of polyunsaturated fatty acids in individuals with autism spectrum disorders].
    Yui K; Koshiba M; Nakamura S; Onishi M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Jun; 31(3):117-24. PubMed ID: 21800702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low density lipoprotein immunoapheresis does not increase plasma lipid peroxidation products in vivo.
    Kostner K; Banyai S; Jansen M; Khoschsorur G; Hörl WH; Maurer G; Winklhofer-Roob B; Derfler K
    Clin Chim Acta; 1999 Oct; 288(1-2):21-30. PubMed ID: 10529454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Predictive Role of Lipid Peroxidation Markers for Type 2 Diabetes in the Adult Tunisian Population.
    Bouhajja H; Kacem FH; Abdelhedi R; Ncir M; Dimitrov JD; Marrakchi R; Jamoussi K; Rebai A; El Feki A; Abid M; Ayadi H; Kaveri SV; Mnif-Feki M; Bougacha-Elleuch N
    Can J Diabetes; 2018 Jun; 42(3):263-271. PubMed ID: 28734952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating antibodies recognizing oxidatively modified low-density lipoprotein in children.
    Iughetti L; Volta C; Maggi E; Palladini G; Perugini C; Bellomo G; Bernasconi S
    Pediatr Res; 1999 Jan; 45(1):94-9. PubMed ID: 9890615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD.
    Roob JM; Rabold T; Hayn M; Khoschsorur G; Resch U; Holzer H; Winklhofer-Roob BM
    Kidney Int Suppl; 2001 Feb; 78():S128-36. PubMed ID: 11168998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased low-density lipoprotein peroxidation in elderly men.
    Napoli C; Abete P; Corso G; Malorni A; Postiglione A; Ambrosio G; Cacciatore F; Rengo F; Palumbo G
    Coron Artery Dis; 1997; 8(3-4):129-36. PubMed ID: 9237021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of three rapeseed oil-rich diets, fortified with alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on the composition and oxidizability of low-density lipoproteins: results of a controlled study in healthy volunteers.
    Egert S; Somoza V; Kannenberg F; Fobker M; Krome K; Erbersdobler HF; Wahrburg U
    Eur J Clin Nutr; 2007 Mar; 61(3):314-25. PubMed ID: 16969378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative modification of low-density lipoprotein and atherogenetic risk in beta-thalassemia.
    Livrea MA; Tesoriere L; Maggio A; D'Arpa D; Pintaudi AM; Pedone E
    Blood; 1998 Nov; 92(10):3936-42. PubMed ID: 9808587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.